David L Sloman

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoshen Ma, David L Sloman, Ruchia Duggal, Kenneth D Anderson, Jeanine E Ballard, Indu Bharathan, Christopher Brynczka, Symon Gathiaka, Timothy J Henderson, Thomas W Lyons, Richard Miller, Erik V Munsell, Peter Orth, Ryan D Otte, Anandan Palani, Danica A Rankic, Michelle R Robinson, Aaron C Sather, Nicolas Solban, Xuelei Sherry Song, Xin Wen, Zangwei Xu, Yi Yang, Ruojing Yang, Phil J Day, Alexander Stoeck, David Jonathan Bennett, Yongxin Han
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS G12C Inhibitor. Journal of medicinal chemistry 67 (13) (2024)
Esra Balıkçı, Anne-Sophie M C Marques, Ludwig G Bauer, Raina Seupel, James M Bennett, Brigitt Raux, Karly Buchan, Klemensas Simelis, Usha Singh, Catherine Rogers, Jennifer Ward, Carol Cheng, Tamas Szommer, Kira Schützenhofer, Jonathan M Elkins, David L Sloman, Ivan Ahel, Oleg Fedorov, Paul E Brennan, Kilian V M Huber
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. Journal of medicinal chemistry 67 (9) (2024)
Xiaoshen Ma, David L Sloman, Ruchia Duggal, Kenneth D Anderson, Jeanine E Ballard, Indu Bharathan, Christopher Brynczka, Symon Gathiaka, Timothy J Henderson, Thomas W Lyons, Richard Miller, Erik V Munsell, Peter Orth, Ryan D Otte, Anandan Palani, Danica A Rankic, Michelle R Robinson, Aaron C Sather, Nicolas Solban, Xuelei Sherry Song, Xin Wen, Zangwei Xu, Yi Yang, Ruojing Yang, Phil J Day, Alexander Stoeck, David Jonathan Bennett, Yongxin Han
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS G12C Inhibitor. Journal of medicinal chemistry 67 (13) (2024)
Esra Balıkçı, Anne-Sophie M C Marques, Ludwig G Bauer, Raina Seupel, James M Bennett, Brigitt Raux, Karly Buchan, Klemensas Simelis, Usha Singh, Catherine Rogers, Jennifer Ward, Carol Cheng, Tamas Szommer, Kira Schützenhofer, Jonathan M Elkins, David L Sloman, Ivan Ahel, Oleg Fedorov, Paul E Brennan, Kilian V M Huber
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. Journal of medicinal chemistry 67 (9) (2024)
Esra Balıkçı, Anne-Sophie M C Marques, Ludwig G Bauer, Raina Seupel, James M Bennett, Brigitt Raux, Karly Buchan, Klemensas Simelis, Usha Singh, Catherine Rogers, Jennifer Ward, Carol Cheng, Tamas Szommer, Kira Schützenhofer, Jonathan M Elkins, David L Sloman, Ivan Ahel, Oleg Fedorov, Paul E Brennan, Kilian V M Huber
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. Journal of medicinal chemistry (2024)
Xiaoshen Ma, David L Sloman, Ruchia Duggal, Kenneth D Anderson, Jeanine E Ballard, Indu Bharathan, Christopher Brynczka, Symon Gathiaka, Timothy J Henderson, Thomas W Lyons, Richard Miller, Erik V Munsell, Peter Orth, Ryan D Otte, Anandan Palani, Danica A Rankic, Michelle R Robinson, Aaron C Sather, Nicolas Solban, Xuelei Sherry Song, Xin Wen, Zangwei Xu, Yi Yang, Ruojing Yang, Phil J Day, Alexander Stoeck, David Jonathan Bennett, Yongxin Han
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS G12C Inhibitor. Journal of medicinal chemistry (2024)
Esra Balıkçı, Anne-Sophie M C Marques, Ludwig G Bauer, Raina Seupel, James M Bennett, Brigitt Raux, Karly Buchan, Klemensas Simelis, Usha Singh, Catherine Rogers, Jennifer Ward, Carol Cheng, Tamas Szommer, Kira Schützenhofer, Jonathan M Elkins, David L Sloman, Ivan Ahel, Oleg Fedorov, Paul E Brennan, Kilian V M Huber
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. Journal of medicinal chemistry 67 (9) (2024)
Derun Li, David L Sloman, Abdelghani Achab, Hua Zhou, Meredeth A McGowan, Catherine White, Craig Gibeau, Hongjun Zhang, Qinglin Pu, Indu Bharathan, Brett Hopkins, Kun Liu, Heidi Ferguson, Andreas Verras, Charles A Lesburg, Theodore A Martinot, Ji Qi, Zhiguo J Song, Jingjun Yin, Huangguang Zhang, Licheng Song, Baoqiang Wan, Suzanne M D'Addio, Nicolas Solban, J Richard Miller, Beata Zamlynny, Alan Bass, Elizabeth Freeland, Bridget Ykoruk, Catherine Hilliard, Jude Ferraro, Jin Zhai, Ian Knemeyer, Karin M Otte, Stella Vincent, Nunzio Sciammetta, Alexander Pasternak, David Jonathan Bennett, Yongxin Han
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing. Journal of medicinal chemistry 65 (8) (2022)
Chunhui Huang, Christian Fischer, Michelle R Machacek, Stephane Bogen, Tesfaye Biftu, Xianhai Huang, Michael H Reutershan, Ryan Otte, Qingmei Hong, Zhicai Wu, Yang Yu, Min Park, Lei Chen, Purakkattle Biju, Ian Knemeyer, Ping Lu, Christopher J Kochansky, Michael Brendan Hicks, Yong Liu, Roy Helmy, Andreas Verras, Anthony Donofrio, Josh Close, Matthew L Maddess, Catherine White, David L Sloman, Nunzio Sciammetta, Jun Lu, Craig Gibeau, Vladimir Simov, Hongjun Zhang, Peter Fuller, David Witter
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors. ACS medicinal chemistry letters 13 (4) (2022)
Derun Li, Hongjun Zhang, Thomas W Lyons, Min Lu, Abdelghani Achab, Qinglin Pu, Matthew Childers, Matthew J Mitcheltree, Jialiang Wang, Theodore A Martinot, Spencer E McMinn, David L Sloman, Anandan Palani, Adam Beard, Lisa Nogle, Symon Gathiaka, Josep Saurí, Hai-Young Kim, Donovon Adpressa, Peter Spacciapoli, J Richard Miller, Rachel L Palte, Charles A Lesburg, Jared Cumming, Christian Fischer
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors. ACS medicinal chemistry letters 12 (11) (2021)

David L Sloman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David L Sloman